cycloanthranilylproline,
(S)-(+)-2,3-Dihydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5,11(10H,11aH)-dione,
138865-23-3,
Cycloanthranilylproline,
PBD-5,11-dione,
AC1LDY19,
Oprea1_043936,
CHEMBL388863,
SCHEMBL7270310,
ZINC40627,
MXBNEEHQIDLPLQ-JTQLQIEISA-N,
BB_NC-01530,
MFCD00075201,
AKOS000773648,
MCULE-5083849676,
NCGC00160211-01,
BC4526270,
DB-065656,
(11As)-Pyrrolo[2,1-C][1,4]Benzodiazepine,
SR-01000375357,
J-012166,
SR-01000375357-1,
(11aS)-1,2,3,10,11,11a-Hexahydro-5H-Pyrrolo[2,1-c][1,4]Benzodiazepin-5,11-Dione,
(6aS)-6a,7,8,9-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepine-6,11-dione,
(S)-(+)-2,3-dihydro-1H-pyrrolo[2,1-c][1,4]benzodiazapine-5,11(10H,11aH)-dione,
(S)-(+)-2,3-Dihydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5,11(10H,11aH)-dione, 99%,
(S)-1,2,3,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepine-5,11(10H)-dione,
(S)-2,3-dihydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepine-5,11(10H,11aH)-dione,
1H-Pyrrolo[2,1-c][1,4]benzodiazepine-5,11(10H,11ah)-dione,2,3-dihydro-,hydrate(1:2),(11as)-,
NCGC00160211-01!2,3-Dihydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5,11(10H,11aH)-dione,
CID677114,
ZINC00040628,
18877-34-4,